Dixon Investments Inc.
FDA inspection history in Orchard Hill, Georgia, 2019 to 2025
- 1
- Warning letter
- 1
- Form 483
Every document, by year
- Warning letter
- Form 483
2019: one Form 483; 2025: one warning letter.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Orchard Hill, Georgia.
- 2025One warning letter, at Orchard Hill, Georgia.
Cited most
Across all Dixon Investments observations on file
- 21 CFR 211.165(a)Testing and release for distribution2
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.160(b)General requirements1
- 21 CFR 211.166(b)Stability testing1
- 21 CFR 211.180(e)(2)General requirements1
The complete Dixon Investments file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Orchard Hill, Georgia
One warning letter and one Form 483 · 2019 to 2025 · 7 observations
Latest: Warning letter, Sep 17, 2025 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2025-09-17 | Warning letter Warning letter | Orchard Hill, Georgia | — | $99 |
| 2019-03-22 | 483 Form 483 | Orchard Hill, Georgia | 7 | $99 |
Investigators on these documents
FEI number 1037559 · most recent document Sep 17, 2025
About Dixon Investments Inc.
How many FDA Form 483s has Dixon Investments Inc. received?
FDA Intel has 1 Form 483 on file for Dixon Investments Inc.; the most recent is dated Mar 22, 2019.
When was Dixon Investments Inc. last inspected by FDA?
The most recent FDA inspection document on file for Dixon Investments Inc. is a Form 483 dated Mar 22, 2019, for the site in Orchard Hill, Georgia.
What did FDA cite at Dixon Investments Inc.?
The regulations cited most in the observations on file for Dixon Investments Inc. are 21 CFR 211.165(a) (Testing and release for distribution), 2 times; 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.160(b) (General requirements), 1 time.
Has Dixon Investments Inc. received an FDA warning letter?
Yes. FDA Intel has 1 FDA warning letter on file for Dixon Investments Inc.; the most recent is dated Sep 17, 2025.